Hepatocellular carcinoma treatment with transcatheter arterial chemoembolization: Evaluation with contrast-enhanced harmonic power Doppler ultrasound

L. Crocetti, R. Lencioni, D. Cioni, A. Paolicchi, C. Franchini, B. Degl'Innocenti, C. Bartolozzi

Research output: Contribution to journalConference article

Abstract

The usefulness of contrast-enhanced harmonic power Doppler ultrasound (US) in evaluating the therapeutic response of hepatocellular carcinoma (HCC) to transcatheter arterial chemoembolization (TACE) is investigated. Dual-phase spiral CT and contrast-enhanced dynamic magnetic resonance (MR) imaging are performed to establish the outcome of therapy. Twenty-eight of the 38 lesions underwent additional treatment with percutaneous ethanol injection (PEI) by targeting the areas of residual tumor with contrast-enhanced harmonic power Doppler US guidance. Contrast-enhanced harmonic power Doppler US proved useful for assessing the therapeutic effect of TACE on HCC and may be used to target additional treatment with PEI in cases of partial response.

Original languageEnglish (US)
Pages (from-to)A132
JournalUltrasound in Medicine and Biology
Volume26
Issue numberSUPPL. 2
StatePublished - Jan 1 2000
EventThe 9th Congress of World Federation for Ultrasound in Medicine and Biology - Florence, Italy
Duration: May 6 2000May 10 2000

    Fingerprint

ASJC Scopus subject areas

  • Biophysics
  • Radiological and Ultrasound Technology
  • Acoustics and Ultrasonics

Cite this

Crocetti, L., Lencioni, R., Cioni, D., Paolicchi, A., Franchini, C., Degl'Innocenti, B., & Bartolozzi, C. (2000). Hepatocellular carcinoma treatment with transcatheter arterial chemoembolization: Evaluation with contrast-enhanced harmonic power Doppler ultrasound. Ultrasound in Medicine and Biology, 26(SUPPL. 2), A132.